Patents Assigned to HANX BIOPHARMACEUTICS, INC
  • Anti-PD-1/CD47 bispecific antibody and application thereof
    Patent number: 11680099
    Abstract: The present invention provides a recombinant protein. The recombinant protein includes an anti-PD-1 antibody and human SIRPA extracellular domain. The N-terminus of the human SIRPA extracellular domain is linked to the C-terminus of the heavy chain of the anti-PD-1 antibody.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: June 20, 2023
    Assignee: HANX BIOPHARMACEUTICS, INC
    Inventors: Ying Huang, Faming Zhang, Gan Xi